Effects of monoamine reuptake blockade on ponto-geniculo-occipital wave activity
Norepinephrine (NE) and serotonin (5HT) likely inhibit the generation of ponto-geniculo-occipital (PGO) waves. Either desipramine (DMI) or sertraline (SER:1S,4S-N-methyl-4-(3,4-dichlorophenyl)-1,2,3,4-cetrahydro-1-naphthylamine) was administered in the cat for 2.5 weeks to probe noradrenergic and se...
Gespeichert in:
| Veröffentlicht in: | Neuropharmacology 1990-10, Vol.29 (10), p.965-968 |
|---|---|
| Hauptverfasser: | , , , , |
| Format: | Artikel |
| Sprache: | eng |
| Schlagworte: | |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | 968 |
|---|---|
| container_issue | 10 |
| container_start_page | 965 |
| container_title | Neuropharmacology |
| container_volume | 29 |
| creator | Ross, R.J. Ball, W.A. Levitt, D.R. Gresch, P.J. Morrison, A.R. |
| description | Norepinephrine (NE) and serotonin (5HT) likely inhibit the generation of ponto-geniculo-occipital (PGO) waves. Either desipramine (DMI) or sertraline (SER:1S,4S-N-methyl-4-(3,4-dichlorophenyl)-1,2,3,4-cetrahydro-1-naphthylamine) was administered in the cat for 2.5 weeks to probe noradrenergic and serotonergic mechanisms, respectively. Placebo days were compared with the first day of drug and with days that followed 2.5 weeks of drug (chronic). PGO rates during REM sleep and the preceding transition period were significantly decreased by either chronic DMI or SER. Cat PGO waves resemble waves that accompany alerting to intense or novel stimuli in wakefulness. Depressive disorders in humans have features of hyperarousal; PGO wave suppression by antidepressant drugs may relate to clinical antidepressant actions. |
| doi_str_mv | 10.1016/0028-3908(90)90149-L |
| format | Article |
| fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_15785610</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>002839089090149L</els_id><sourcerecordid>15785610</sourcerecordid><originalsourceid>FETCH-LOGICAL-c379l-557a74a56eb5357b4fa76452e0c0eb2969c1c07021d7ce8028a725868a3b24b03</originalsourceid><addsrcrecordid>eNp9kE1v1DAQhi0EKkvhH4CUCwgOgXFix_alEqrKh7QSHOBsTSYTZJrEwU4W9d-TZVflxmkO87yvZh4hnkt4K0E27wAqW9YO7GsHbxxI5cr9A7GT1tSlgUY9FLt75LF4kvNPAFBW2gtxUVVa19btxNebvmdachH7YoxTxDFMXCRe5wVvuWiHSLfYcRGnYo7TEssfPAVah1hGojCHBYfiNx64QFrCISx3T8WjHofMz87zUnz_cPPt-lO5__Lx8_X7fUm1cUOptUGjUDfc6lqbVvVoGqUrBgJuK9c4kgQGKtkZYrv9gabStrFYt5Vqob4Ur069c4q_Vs6LH0MmHgacOK7ZS22sbuQRVCeQUsw5ce_nFEZMd16CP4r0R0v-aMk78H9F-v0We3HuX9uRu_vQ2dy2f3neYyYc-oQThfyv26naGGk27urE8SbjEDj5TIEn4i6kTbzvYvj_IX8A2R6O4Q</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>15785610</pqid></control><display><type>article</type><title>Effects of monoamine reuptake blockade on ponto-geniculo-occipital wave activity</title><source>MEDLINE</source><source>Elsevier ScienceDirect Journals Complete</source><creator>Ross, R.J. ; Ball, W.A. ; Levitt, D.R. ; Gresch, P.J. ; Morrison, A.R.</creator><creatorcontrib>Ross, R.J. ; Ball, W.A. ; Levitt, D.R. ; Gresch, P.J. ; Morrison, A.R.</creatorcontrib><description>Norepinephrine (NE) and serotonin (5HT) likely inhibit the generation of ponto-geniculo-occipital (PGO) waves. Either desipramine (DMI) or sertraline (SER:1S,4S-N-methyl-4-(3,4-dichlorophenyl)-1,2,3,4-cetrahydro-1-naphthylamine) was administered in the cat for 2.5 weeks to probe noradrenergic and serotonergic mechanisms, respectively. Placebo days were compared with the first day of drug and with days that followed 2.5 weeks of drug (chronic). PGO rates during REM sleep and the preceding transition period were significantly decreased by either chronic DMI or SER. Cat PGO waves resemble waves that accompany alerting to intense or novel stimuli in wakefulness. Depressive disorders in humans have features of hyperarousal; PGO wave suppression by antidepressant drugs may relate to clinical antidepressant actions.</description><identifier>ISSN: 0028-3908</identifier><identifier>EISSN: 1873-7064</identifier><identifier>DOI: 10.1016/0028-3908(90)90149-L</identifier><identifier>PMID: 2255389</identifier><identifier>CODEN: NEPHBW</identifier><language>eng</language><publisher>Oxford: Elsevier Ltd</publisher><subject>1-Naphthylamine - analogs & derivatives ; 1-Naphthylamine - pharmacology ; Animals ; Biological and medical sciences ; Biological Transport - drug effects ; Cats ; depression ; Desipramine - pharmacology ; Electroencephalography - drug effects ; Electromyography ; Electrooculography ; Eye Movements - drug effects ; Female ; Fundamental and applied biological sciences. Psychology ; Geniculate Bodies - drug effects ; Geniculate Bodies - physiology ; monoamines ; norepinephrine ; Norepinephrine - metabolism ; Norepinephrine - physiology ; Occipital Lobe - drug effects ; Occipital Lobe - physiology ; PGO waves ; Pons - drug effects ; Pons - physiology ; reuptake blockade ; serotonin ; Serotonin - metabolism ; Serotonin - physiology ; Serotonin Antagonists - pharmacology ; Sertraline ; Sleep, REM - drug effects ; Sleep. Vigilance ; Vertebrates: nervous system and sense organs</subject><ispartof>Neuropharmacology, 1990-10, Vol.29 (10), p.965-968</ispartof><rights>1990</rights><rights>1991 INIST-CNRS</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c379l-557a74a56eb5357b4fa76452e0c0eb2969c1c07021d7ce8028a725868a3b24b03</citedby><cites>FETCH-LOGICAL-c379l-557a74a56eb5357b4fa76452e0c0eb2969c1c07021d7ce8028a725868a3b24b03</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://dx.doi.org/10.1016/0028-3908(90)90149-L$$EHTML$$P50$$Gelsevier$$H</linktohtml><link.rule.ids>314,780,784,3550,27924,27925,45995</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=19437717$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/2255389$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Ross, R.J.</creatorcontrib><creatorcontrib>Ball, W.A.</creatorcontrib><creatorcontrib>Levitt, D.R.</creatorcontrib><creatorcontrib>Gresch, P.J.</creatorcontrib><creatorcontrib>Morrison, A.R.</creatorcontrib><title>Effects of monoamine reuptake blockade on ponto-geniculo-occipital wave activity</title><title>Neuropharmacology</title><addtitle>Neuropharmacology</addtitle><description>Norepinephrine (NE) and serotonin (5HT) likely inhibit the generation of ponto-geniculo-occipital (PGO) waves. Either desipramine (DMI) or sertraline (SER:1S,4S-N-methyl-4-(3,4-dichlorophenyl)-1,2,3,4-cetrahydro-1-naphthylamine) was administered in the cat for 2.5 weeks to probe noradrenergic and serotonergic mechanisms, respectively. Placebo days were compared with the first day of drug and with days that followed 2.5 weeks of drug (chronic). PGO rates during REM sleep and the preceding transition period were significantly decreased by either chronic DMI or SER. Cat PGO waves resemble waves that accompany alerting to intense or novel stimuli in wakefulness. Depressive disorders in humans have features of hyperarousal; PGO wave suppression by antidepressant drugs may relate to clinical antidepressant actions.</description><subject>1-Naphthylamine - analogs & derivatives</subject><subject>1-Naphthylamine - pharmacology</subject><subject>Animals</subject><subject>Biological and medical sciences</subject><subject>Biological Transport - drug effects</subject><subject>Cats</subject><subject>depression</subject><subject>Desipramine - pharmacology</subject><subject>Electroencephalography - drug effects</subject><subject>Electromyography</subject><subject>Electrooculography</subject><subject>Eye Movements - drug effects</subject><subject>Female</subject><subject>Fundamental and applied biological sciences. Psychology</subject><subject>Geniculate Bodies - drug effects</subject><subject>Geniculate Bodies - physiology</subject><subject>monoamines</subject><subject>norepinephrine</subject><subject>Norepinephrine - metabolism</subject><subject>Norepinephrine - physiology</subject><subject>Occipital Lobe - drug effects</subject><subject>Occipital Lobe - physiology</subject><subject>PGO waves</subject><subject>Pons - drug effects</subject><subject>Pons - physiology</subject><subject>reuptake blockade</subject><subject>serotonin</subject><subject>Serotonin - metabolism</subject><subject>Serotonin - physiology</subject><subject>Serotonin Antagonists - pharmacology</subject><subject>Sertraline</subject><subject>Sleep, REM - drug effects</subject><subject>Sleep. Vigilance</subject><subject>Vertebrates: nervous system and sense organs</subject><issn>0028-3908</issn><issn>1873-7064</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>1990</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNp9kE1v1DAQhi0EKkvhH4CUCwgOgXFix_alEqrKh7QSHOBsTSYTZJrEwU4W9d-TZVflxmkO87yvZh4hnkt4K0E27wAqW9YO7GsHbxxI5cr9A7GT1tSlgUY9FLt75LF4kvNPAFBW2gtxUVVa19btxNebvmdachH7YoxTxDFMXCRe5wVvuWiHSLfYcRGnYo7TEssfPAVah1hGojCHBYfiNx64QFrCISx3T8WjHofMz87zUnz_cPPt-lO5__Lx8_X7fUm1cUOptUGjUDfc6lqbVvVoGqUrBgJuK9c4kgQGKtkZYrv9gabStrFYt5Vqob4Ur069c4q_Vs6LH0MmHgacOK7ZS22sbuQRVCeQUsw5ce_nFEZMd16CP4r0R0v-aMk78H9F-v0We3HuX9uRu_vQ2dy2f3neYyYc-oQThfyv26naGGk27urE8SbjEDj5TIEn4i6kTbzvYvj_IX8A2R6O4Q</recordid><startdate>199010</startdate><enddate>199010</enddate><creator>Ross, R.J.</creator><creator>Ball, W.A.</creator><creator>Levitt, D.R.</creator><creator>Gresch, P.J.</creator><creator>Morrison, A.R.</creator><general>Elsevier Ltd</general><general>Elsevier</general><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7TK</scope></search><sort><creationdate>199010</creationdate><title>Effects of monoamine reuptake blockade on ponto-geniculo-occipital wave activity</title><author>Ross, R.J. ; Ball, W.A. ; Levitt, D.R. ; Gresch, P.J. ; Morrison, A.R.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c379l-557a74a56eb5357b4fa76452e0c0eb2969c1c07021d7ce8028a725868a3b24b03</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>1990</creationdate><topic>1-Naphthylamine - analogs & derivatives</topic><topic>1-Naphthylamine - pharmacology</topic><topic>Animals</topic><topic>Biological and medical sciences</topic><topic>Biological Transport - drug effects</topic><topic>Cats</topic><topic>depression</topic><topic>Desipramine - pharmacology</topic><topic>Electroencephalography - drug effects</topic><topic>Electromyography</topic><topic>Electrooculography</topic><topic>Eye Movements - drug effects</topic><topic>Female</topic><topic>Fundamental and applied biological sciences. Psychology</topic><topic>Geniculate Bodies - drug effects</topic><topic>Geniculate Bodies - physiology</topic><topic>monoamines</topic><topic>norepinephrine</topic><topic>Norepinephrine - metabolism</topic><topic>Norepinephrine - physiology</topic><topic>Occipital Lobe - drug effects</topic><topic>Occipital Lobe - physiology</topic><topic>PGO waves</topic><topic>Pons - drug effects</topic><topic>Pons - physiology</topic><topic>reuptake blockade</topic><topic>serotonin</topic><topic>Serotonin - metabolism</topic><topic>Serotonin - physiology</topic><topic>Serotonin Antagonists - pharmacology</topic><topic>Sertraline</topic><topic>Sleep, REM - drug effects</topic><topic>Sleep. Vigilance</topic><topic>Vertebrates: nervous system and sense organs</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Ross, R.J.</creatorcontrib><creatorcontrib>Ball, W.A.</creatorcontrib><creatorcontrib>Levitt, D.R.</creatorcontrib><creatorcontrib>Gresch, P.J.</creatorcontrib><creatorcontrib>Morrison, A.R.</creatorcontrib><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Neurosciences Abstracts</collection><jtitle>Neuropharmacology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Ross, R.J.</au><au>Ball, W.A.</au><au>Levitt, D.R.</au><au>Gresch, P.J.</au><au>Morrison, A.R.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Effects of monoamine reuptake blockade on ponto-geniculo-occipital wave activity</atitle><jtitle>Neuropharmacology</jtitle><addtitle>Neuropharmacology</addtitle><date>1990-10</date><risdate>1990</risdate><volume>29</volume><issue>10</issue><spage>965</spage><epage>968</epage><pages>965-968</pages><issn>0028-3908</issn><eissn>1873-7064</eissn><coden>NEPHBW</coden><abstract>Norepinephrine (NE) and serotonin (5HT) likely inhibit the generation of ponto-geniculo-occipital (PGO) waves. Either desipramine (DMI) or sertraline (SER:1S,4S-N-methyl-4-(3,4-dichlorophenyl)-1,2,3,4-cetrahydro-1-naphthylamine) was administered in the cat for 2.5 weeks to probe noradrenergic and serotonergic mechanisms, respectively. Placebo days were compared with the first day of drug and with days that followed 2.5 weeks of drug (chronic). PGO rates during REM sleep and the preceding transition period were significantly decreased by either chronic DMI or SER. Cat PGO waves resemble waves that accompany alerting to intense or novel stimuli in wakefulness. Depressive disorders in humans have features of hyperarousal; PGO wave suppression by antidepressant drugs may relate to clinical antidepressant actions.</abstract><cop>Oxford</cop><pub>Elsevier Ltd</pub><pmid>2255389</pmid><doi>10.1016/0028-3908(90)90149-L</doi><tpages>4</tpages><oa>free_for_read</oa></addata></record> |
| fulltext | fulltext |
| identifier | ISSN: 0028-3908 |
| ispartof | Neuropharmacology, 1990-10, Vol.29 (10), p.965-968 |
| issn | 0028-3908 1873-7064 |
| language | eng |
| recordid | cdi_proquest_miscellaneous_15785610 |
| source | MEDLINE; Elsevier ScienceDirect Journals Complete |
| subjects | 1-Naphthylamine - analogs & derivatives 1-Naphthylamine - pharmacology Animals Biological and medical sciences Biological Transport - drug effects Cats depression Desipramine - pharmacology Electroencephalography - drug effects Electromyography Electrooculography Eye Movements - drug effects Female Fundamental and applied biological sciences. Psychology Geniculate Bodies - drug effects Geniculate Bodies - physiology monoamines norepinephrine Norepinephrine - metabolism Norepinephrine - physiology Occipital Lobe - drug effects Occipital Lobe - physiology PGO waves Pons - drug effects Pons - physiology reuptake blockade serotonin Serotonin - metabolism Serotonin - physiology Serotonin Antagonists - pharmacology Sertraline Sleep, REM - drug effects Sleep. Vigilance Vertebrates: nervous system and sense organs |
| title | Effects of monoamine reuptake blockade on ponto-geniculo-occipital wave activity |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-28T03%3A42%3A56IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Effects%20of%20monoamine%20reuptake%20blockade%20on%20ponto-geniculo-occipital%20wave%20activity&rft.jtitle=Neuropharmacology&rft.au=Ross,%20R.J.&rft.date=1990-10&rft.volume=29&rft.issue=10&rft.spage=965&rft.epage=968&rft.pages=965-968&rft.issn=0028-3908&rft.eissn=1873-7064&rft.coden=NEPHBW&rft_id=info:doi/10.1016/0028-3908(90)90149-L&rft_dat=%3Cproquest_cross%3E15785610%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=15785610&rft_id=info:pmid/2255389&rft_els_id=002839089090149L&rfr_iscdi=true |